Index test:PET/CT

4 trials

Sponsors

China-Japan Friendship Hospital, Fudan University Shanghai Cancer Center, Xingtai People's Hospital, Affiliated Cancer Hospital and Institute of Guangzhou Medical University

Conditions

Patients with clinical suspicion or possible primary or recurrent malignant tumors (such as gliomas, liver cancer, gastric cancer, duodenal cancer, colorectal cancer, ovarian cancer and other malignancies prone to false-negative or false-positive results with 18F-FDG)Pulmonary Artery SarcomaTumorrecurrence and metastasis of lung cancer

Early Phase 1

Clinical Application Study of FAPI-FUSCC-07 PET/CT Tumor Imaging

Active, not recruitingChiCTR2400089492

Fudan University Shanghai Cancer CenterTumor

Start: 2024-09-13Updated: 2024-09-16

Unknown Phase

Value of 18F-FDG PET/CT in in the diagnosis and differential diagnosis of pulmonary artery sarcoma

RecruitingChiCTR2000039230

China-Japan Friendship HospitalPulmonary Artery Sarcoma

Start: 2020-11-01Updated: 2021-01-25

Application value of 18F-FDG PET/CT combined with tumor markers in postoperative recurrence and metastasis of lung cancer

Active, not recruitingChiCTR2600130883

Xingtai People's Hospitalrecurrence and metastasis of lung cancer

Start: 2026-09-01Updated: 2026-08-31

A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT

RecruitingChiCTR2600132724

Affiliated Cancer Hospital and Institute of Guangzhou Medical UniversityPatients with clinical suspicion or possible primary or recurrent malignant tumors (such as gliomas, liver cancer, gastric cancer, duodenal cancer, colorectal cancer, ovarian cancer and other malignancies prone to false-negative or false-positive results with 18F-FDG)

Start: 2025-12-05Updated: 2026-09-21